Enhancing Uptake of Needle and Syringe Programs in Canadian Federal Prisons

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMcGill University Health Centre/Research Institute of the McGill University Health Centre

About this trial

This study is focused on improving the implementation of Prison Needle Exchange Programs (PNEPs) in Canadian federal prisons, with the goal of increasing the uptake of these programs among people who inject drugs in prison. The study is being conducted in nine federal prisons, including five women's prisons, where a higher proportion of incarcerated individuals report a history of injection drug use. This study aims to improve PNEP adoption and sustainability by identifying barriers and facilitators and implementing evidence-based strategies to enhance program engagement.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

All people incarcerated at a study site during the intervention period

Disqualifiers

None

Trial design

Design model

Sequential

Treatments tested in this trial

  • NIATx

    Behavioral

    The Network for the Improvement of Addiction Treatment (NIATx) model uses a bundle of implementation tools that include expert facilitation (coaching) and quality process improvement specifically for behavioural healthcare settings to improve access and retention in treatment.

Treatment groups

548 Participants
are divided into 3 treatment groups
Group A: NIATx group 1Experimental treatment 1 intervention
Group B: NIATx group 2Experimental treatment 1 intervention
Group C: NIATx group 3Experimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Effectiveness

Number of participants on the PNEP

Time frame
From start to end of intervention period (24 months)

Secondary outcomes

1

Bloodborne virus cascade of care

Number of HIV and hepatitis C virus screenings/tests, diagnoses, and treatment initiations, among the total prison population

Time frame
From start to end of intervention period (24 months)
2

Enrollment in opioid agonist therapy

The number of people who inject drugs who access opioid agonist therapy among the total prison population

Time frame
From start to end of intervention period (24 months)

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

McGill University Health Centre/Research Institute of the McGill University Health Centre

Lead sponsor

Yale University

Collaborator

Burnet Institute

Collaborator

Kirby Institute

Collaborator